“The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients” (2017) Farmeconomia. Health economics and therapeutic pathways, 18(1). doi:10.7175/fe.v18i1.1325.